The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs

F. Meheus, A.A. Abuzaid, R. Baltussen, B.M. Younis, M. Balasegaram, E.A. Khalil, M. Boelaert, A.M. Musa

    Research output: Contribution to journalA1: Web of Science-article

    Abstract

    Visceral leishmaniasis (VL) is a neglected parasitic disease that is fatal if left untreated and is endemic in eastern Sudan. We estimated the direct and indirect costs of treatment of VL from the perspective of the provider and the household at three public hospitals in Gedaref State. The median total cost for one VL episode was estimated to be US$450. Despite the free provision of VL drugs at public hospitals, households bore 53% of the total cost of VL with one episode of VL representing 40% of the annual household income. More than 75% of households incurred catastrophic out-of-pocket expenditures. The length of treatment of 30 days led to important costs for both health providers and households. Alternative treatment regimens that reduce the duration of treatment are urgently needed.
    Original languageEnglish
    JournalAmerican Journal of Tropical Medicine and Hygiene
    Volume89
    Issue number6
    Pages (from-to)1146-1153
    Number of pages8
    ISSN0002-9637
    DOIs
    Publication statusPublished - 2013

    Fingerprint

    Dive into the research topics of 'The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs'. Together they form a unique fingerprint.

    Cite this